HemaCare Co. (OTCMKTS:HEMA – Get Free Report)’s share price shot up 0.6% during trading on Wednesday . The company traded as high as $25.31 and last traded at $25.31. 5,400 shares traded hands during trading, a decline of 86% from the average session volume of 39,950 shares. The stock had previously closed at $25.16.
HemaCare Stock Performance
The stock has a 50 day simple moving average of $25.31 and a 200 day simple moving average of $25.31.
HemaCare Company Profile
HemaCare Corporation provides human-derived primary blood cells and tissues for biomedical research, and supporting cell therapy clinical trials and commercialization with apheresis collections in the United States. The company specializes in the customized collection, isolation, and testing of primary human blood cells and other biological products for research protocols and cellular therapy.
See Also
- Five stocks we like better than HemaCare
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 4 Social Media Stocks Set to Gain as TikTok Ban Looms
- How to Effectively Use the MarketBeat Ratings Screener
- How Do Stock Buybacks Affect Shareholders?
- 3 Grocery Stocks That Are Proving They Are Still Essential
- JPMorgan Chase & Co. Stock Can Hit $300 This Year
Receive News & Ratings for HemaCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HemaCare and related companies with MarketBeat.com's FREE daily email newsletter.
